Wan Wenguo, the captain of the container ship Newnew Polar Bear, is alleged to have caused "criminal damage" to an underwater ...

As of 1009 GMT, the blue-chip index FTSE 100 dropped 1.4% and the British GBP/USD gained 0.4% against the dollar to 1.34. DAX index in Germany fell 1.6%, the CAC 40 in France dropped 1.3%.

Investing.com -- Renault maintained its full-year 2025 guidance set in July, despite a more competitive European auto market and softer year-end trends. The group reiterated confidence in both margins ...

The EUR/USD has been trading in a narrow range between 1.15 and 1.19 in recent months, with positive and negative economic factors on both sides of the Atlantic largely offsetting each other, UBS ...

Investing.com - Shares of French firms exposed to the wine and Champagne industry slipped on Tuesday, after U.S. President Donald Trump threatened to slap 200% tariffs on these goods.

Investing.com -- Deutsche Bank has downgraded Pandora A/S (CSE:PNDORA) shares to “hold” from “buy” rating, citing the recent ...

Forward bookings for 2026 remain strong, with £1.5 billion in revenues already committed. Informa completed a £350 million share buyback in 2025 and has launched a new program for at least £200 ...

As a result of the adjustment, BKW lowered its outlook for 2025 operating profit. The group now expects EBIT of around 540 million to 560 million Swiss francs for the year. Excluding the one-off write ...

European leaders have widely rejected Trump’s calls for Greenland, and were also seen preparing retaliatory measures if Trump ...

Under the agreement, Shionogi will increase its holding in ViiV Healthcare to 21.7%, while GSK will maintain a 78.3% stake. To facilitate this change, ViiV Healthcare will issue new shares to Shionogi ...

Investing.com -- NIOX Group plc (AIM:NIOX), a medical device company specializing in point-of-care FeNO testing for asthma and COPD, on Tuesday reported full-year 2025 revenue growth of 17% to £48.7 ...

Investing.com -- GSK plc (LON:GSK) announced Tuesday it has entered a definitive agreement to acquire RAPT Therapeutics (NASDAQ:RAPT), a California-based clinical-stage biopharmaceutical company, for ...